Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objectives: To investigate obstetric outcomes in Danish women with different phenotypes of polycystic ovary syndrome (PCOS) and isolated hyperandrogenism (HA) and describe the risk of adverse obstetric outcomes in women with PCOS and HA compared to controls. Design: Cohort study. Setting: Odense University Hospital, Denmark. Population: Women with PCOS were identified prospectively starting in 1997. Singleton pregnancies in women with PCOS and HA during 2003–2011 were included (n = 199). A control group was matched to the patient cohort according to date of childbirth (n = 995). Methods: Data on clinical characteristics and obstetric outcomes were collected in patients with PCOS and HA and controls. In PCOS and HA, total and free testosterone, sex hormone binding globulin, and hemoglobin A1c were measured outside pregnancy. During pregnancy, oral glucose tolerance tests were performed in 39 patients and 123 controls according to Danish national guidelines. PCOS phenotypes were based on the Rotterdam criteria. Main outcome measures: Gestational diabetes mellitus, pregnancy‐induced hypertension, preeclampsia, delivery by emergency cesarean section, preterm delivery and anthropometric measures in the newborn. Results: The incidence of adverse obstetric outcomes and anthropometric measures among the newborns were comparable between different phenotypes of PCOS and patients with HA. In the oral glucose tolerance test, patients had a higher risk of gestational diabetes mellitus compared with controls; the odds ratio (95% confidence interval) was 3.3 (1.5–6.9) after adjustment for age, parity, and body mass index (p = 0.002). The incidence of other adverse obstetric outcomes was similar in patients and controls. Conclusions: Obstetric outcomes were comparable in women with different PCOS phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 1×
“The Androgen Excess and PCOS Society suggested that PCOS should be considered a disorder of androgen excess and should be defined by the presence of HA (clinical and/or biochemical) in combination with ovarian dysfunction (anovulation and/or PCO) (9).”
BackgroundDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 3×
“important predictors of metabolic risk in PCOS (5).”
BackgroundDevelopmental origin of polycystic ovary syndrome—a hypothesis
Abbott, D., Dumesic, D., & Franks, S. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740001 · Cited by 504
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Moran, L., & Teede, H. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp008 · Cited by 362 · cited 1×
“BMI was comparable between PCOS phenotypes in the present study, and our findings of comparable obstetric outcomes in different PCOS phenotypes may reflect previous suggestions that obesity is the most important contributing factor for the variation in metabolic risk factors found between different PCOS phenotypes (31…”
ResultQin, J. Z., Pang, L. H., Li, M. J., Fan, X. J., Huang, R. D., & Chen, H. Y. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-56 · Cited by 317 · cited 1×
“A recent meta-analysis, however, stated that available studies on pregnancy outcomes in women with PCOS are of significant heterogeneity and further evidence is needed to establish whether pregnancy in women with PCOS should be managed differently than pregnancies in healthy women (12).”
Androgens in pregnancy: roles in parturition
Makieva, S., Saunders, P. T. K., & Norman, J. E. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu008 · Cited by 232 · cited 1×
“The presence of PCO has been linked to GDM (15) and hyperandrogenemia was associated with preeclampsia and preterm birth in women without PCOS (16).”
BackgroundOligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism
Dewailly, D., Catteau-Jonard, S., Reyss, A.-C., Leroy, M., & Pigny, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1054 · Cited by 198 · cited 1×
“HA was associated with insulin resistance in women with PCOS (6,7) and women with PCOS without HA had milder metabolic abnormalities compared with the phenotypes of PCOS with HA (4,5,8).”
Fetal Macrosomia: Etiologic Factors
LANGER, O. (2000) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-200006000-00006 · Cited by 171 · cited 1×
“HA is closely associated with insulin resistance in PCOS (6,7) and increased birthweight could suggest maternal insulin resistance and glucose intolerance (27).”
Background
Cited by
Bahri Khomami, M., Joham, A. E., Boyle, J. A., Piltonen, T., Silagy, M., Arora, C., Misso, M. L., Teede, H. J., & Moran, L. J. (2019) · Obesity Reviews · doi:10.1111/obr.12829 · Cited by 211
Lizneva, D., Kirubakaran, R., Mykhalchenko, K., Suturina, L., Chernukha, G., Diamond, M. P., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1121 · Cited by 171
Bidhendi Yarandi, R., Behboudi-Gandevani, S., Amiri, M., & Ramezani Tehrani, F. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0453-7 · Cited by 29
Metadata
- Authors
- Mumm, H., Jensen, D. M., Sørensen, J. A., Andersen, L. L. T., Ravn, P., Andersen, M., & Glintborg, D.
- Venue
- Acta Obstetricia et Gynecologica Scandinavica
- Publisher
- Wiley
- Published
- 2014-12-25
- Volume
- 94
- Issue
- 2
- Pages
- 204-211
- ISSN
- 0001-6349 (ISSN-L)
- 1600-0412
- OpenAlex
- W2069585794
- Cited by
- 53
- References
- 8
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.